SBRT, Proton Beam Therapy Use Increasing for Prostate CA

This article originally appeared here.
Share this content:
SBRT, Proton Beam Therapy Use Increasing for Prostate CA
SBRT, Proton Beam Therapy Use Increasing for Prostate CA

MONDAY, June 13, 2016 (HealthDay News) -- For men with prostate cancer, the use of stereotactic body radiotherapy (SBRT) and proton beam therapy increased from 2004 to 2011, according to a study published online May 25 in Cancer.

Joshua A. Halpern, M.D., from the Weill Cornell Medical College in New York City, and colleagues compared temporal trends and outcomes for men with prostate cancer undergoing SBRT, brachytherapy, intensity-modulated radiotherapy (IMRT), and proton beam therapy (542; 9,647; 23,408; and 800 men, respectively) from 2004 to 2011.

The researchers found that the use of SBRT and proton beam therapy increased significantly (P < 0.001), while there was a decrease in brachytherapy use (P < 0.001). Compared with those treated with IMRT and proton beam therapy, a higher percentage of patients treated with SBRT and brachytherapy had low-grade cancer (Gleason score, ≤6 versus ≥7) (35.2 and 49.6 percent versus 54.0 and 64.2 percent, respectively; P < 0.001). Compared with brachytherapy and IMRT, SBRT correlated with equivalent gastrointestinal toxicity, but with more erectile dysfunction at two-year follow-up (P < 0.001). SBRT correlated with more urinary incontinence than IMRT and proton beam therapy. The median costs were $27,154 for SBRT, $17,183 for brachytherapy, $37,090 for IMRT, and $54,706 for proton beam therapy (P < 0.001).

"Despite men of lower disease stage undergoing SBRT, SBRT was found to be associated with greater toxicity but lower health care costs compared with IMRT and proton beam therapy," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Factors ID'd to Predict Fatty Liver in Obese Teens

Factors ID'd to Predict Fatty Liver in Obese ...

African-American obese teens more susceptible to fatty liver effects on glucose metabolism

Patients Prefer Doctors Who Engage in Face-to-Face Visits

Patients Prefer Doctors Who Engage in Face-to-Face Visits

Patients perceive F2F physicians as more compassionate and better communicators

Flexible Sigmoidoscopy Cuts CRC Incidence, Mortality in Men

Flexible Sigmoidoscopy Cuts CRC Incidence, Mortality in Men

Absolute risks for colorectal cancer, CRC death not reduced for screening group vs. controls in women

is free, fast, and customized just for you!

Already a member?

Sign In Now »